Supriya Lifescience Ltd. supplies active pharmaceuticals ingredients (“APIs”), with a focus on research and development. Its products include 39 APIs focused diverse therapeutic segments such as anti-histamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company was founded by Satish Waman Wagh on March 26, 2008 and is headquartered in Mumbai, India.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company